EPA advisory committee
This article was originally published in The Rose Sheet
Executive Summary
Endocrine Disruptor Methods Validation Advisory Committee is being established by the EPA as a source of advice for the agency on matters related to the validation of assays under consideration by the Endocrine Disruptor Screening Program, EPA announces in June 2 Federal Register 1notice. The group will provide recommendations on "scientific and technical aspects of the assays as they progress through the validation process" and also will "provide a forum for a diverse group of individuals representing a broad range of interests and scientific expertise," agency says. In a separate Federal Register notice, EPA announced it will accept nominations of candidates to the committee until June 18...